Clinical Trial to Characterize Pharmacokinetic-pharmacodynamic (PKPD) of Prasugrel 10 mg or 30 mg in Healthy Volunteers

Status:
Unknown status

Trial end date:
2014-02-01

Target enrollment:

Participant gender:

An open label, parallel study to characterize the pharmacokinetics and pharmacodynamics of Prasugrel 30 mg or 60 mg in healthy male adult subjects

Phase 1

Asan Medical Center

Prasugrel Hydrochloride